ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 172 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $9,401,000 | -35.4% | 232,583 | -8.0% | 0.03% | -19.4% |
| Q2 2015 | $14,545,000 | +12.3% | 252,737 | +24.3% | 0.04% | +16.1% |
| Q1 2015 | $12,949,000 | +11.8% | 203,375 | +8.4% | 0.03% | +6.9% |
| Q4 2014 | $11,585,000 | +72.9% | 187,639 | +8.7% | 0.03% | +81.2% |
| Q3 2014 | $6,700,000 | +5.5% | 172,572 | -6.4% | 0.02% | 0.0% |
| Q2 2014 | $6,350,000 | -25.3% | 184,339 | -6.2% | 0.02% | -33.3% |
| Q1 2014 | $8,496,000 | +19.9% | 196,605 | +10.5% | 0.02% | +9.1% |
| Q4 2013 | $7,086,000 | +8.5% | 177,863 | +2.3% | 0.02% | -4.3% |
| Q3 2013 | $6,528,000 | +27.9% | 173,906 | -8.4% | 0.02% | +9.5% |
| Q2 2013 | $5,102,000 | – | 189,890 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |